| Bid Price | 6.50p | High Price | 7.00p |
|---|
| Ask Price | 7.50p | Low Price | 6.50p |
|---|
| Open Price | 7.00p | Spread | 13.33% |
|---|
| Prev Close | 7.00p | Volume | 108,642 |
|---|
Ondine Biomedical Inc. Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| May 8, 2024 | 7.00 | 7.50 | 6.50 | 7.00 | 4,781,295 |
| May 7, 2024 | 6.50 | 7.89 | 6.00 | 7.00 | 1,509,456 |
| May 3, 2024 | 4.50 | 7.00 | 5.00 | 6.60 | 1,172,667 |
| May 2, 2024 | 5.13 | 5.01 | 5.01 | 5.13 | 415 |
Ondine Biomedical Inc. Information
| Name | Ondine Biomedical Inc. | Index | FTSE AIM All Share |
|---|
| ISIN | CA68234M2058 | Epic | OBI |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 15,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 226.75 m | Prev Close | 7.00p |
|---|
| PE Ratio | | Market Cap | £15.32 m |
|---|
| Div Yield | 0 | Div per Share | NaN CAD |
|---|
| EPS | -0.04 CAD | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.928395 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.341758 | Quick Ratio | 1.711052 |
|---|
Ondine Biomedical Inc. Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 08/12/23 | PLAC | Craig Tooman | NED | 173,278 @ £0.09 | £15,595.00 |
| 08/12/23 | PLAC | Carolyn Cross | CEO | 1,093,770 @ £0.09 | £98,439.00 |
| 08/12/23 | PLAC | Junaid Bajwa | NED | 190,610 @ £0.09 | £17,155.00 |
| 08/12/23 | PLAC | Jean Duvall | NED | 207,934 @ £0.09 | £18,714.00 |
| 08/12/23 | PLAC | Michael Farrar | NED | 86,642 @ £0.09 | £7,798.00 |
Ondine Biomedical Inc. News
